It was ultimately dropped from human trials after showing the dangerous cardiac side effect of QT prolongation, but is still widely used in animal research into H3 antagonists / inverse agonists.
The substance was ultimately eliminated from human clinical trials following the discovery of a serious cardiac issue, QT prolongation, but it continues to be employed in animal research into H3 antagonists and inverse agonists.